- Karen Bernstein, PhD, Chairman, Editor-in-Chief, BioCentury Publications Inc
- Laurence Blumberg, MD, Entrepreneur in Residence at The Lang Entrepreneurship Center, Columbia Business School
- Stephen Mon Wei Chang, PhD, Vice President, Research and Development, New York Stem Cell Foundation
- Ron Cohen, MD, President & CEO, Acorda Therapeutics, Inc.
- Barry Coller, MD, Vice President, Medical Affairs, Physician-in-Chief, The Rockefeller University
- Ellen B. Corenswet, Partner, Covington & Burling LLP
- Pamela Demain, MBA, Executive Director, Corporate Licensing, Merck & Co., Inc.
- Eric Elenko, PhD, Partner, PureTech Ventures
- Gerald Fischbach, MD, Scientific Director, Simons Foundation
- Allan Goldberg, Chief Executive Officer, Avacyn Pharmaceuticals
- Julia P. Gregory, Executive Vice President and Chief Financial Officer, ContraFect
- Michael Gutch, PhD, Managing Director, MedImmune Ventures
- Kimberly Ha, Senior Director, FTI Consulting
- Cláudia Hirawat, President, PTC Therapeutics
- Nouhad T. Husseini, Senior Director, Business Development, Regeneron Pharmaceuticals, Inc.
- Kenneth Kaushansky, MD, MACP, Senior Vice President, Health Sciences Dean, School of Medicine, Stony Brook University
- Lynn D. Kramer, MD, President, Neuroscience Product Creation Unit, Eisai
- Yung S. Lie, PhD, Scientific Director, Damon Runyon Cancer Research Foundation
- Ginny Llobell, Vice President, Defined Health
- Joel S. Marcus, Chairman, Chief Executive Officer & Founder, Alexandria Real Estate Equities, Inc/ Alexandria Venture Investments
- Ronald Newbold, PhD, Vice President, Strategic Research Partnerships, Pfizer Inc
- Timothy J. Pelura, PhD, President, BioEntrep
- Glenn D. Prestwich, PhD, Presidential Professor, Medicinal Chemistry, University of Utah
- Linda M. Pullan, PhD, Principal, Pullan Consulting
- Barbara Ryan, Managing Director, Strategic Communications Practice, FTI Consulting
- Charles Ryan, PhD, JD, VP & Chief Intellectual Property Counsel, Forest Laboratories, Inc.
- Todd Sherer, PhD, Chief Executive Officer, The Michael J. Fox Foundation for Parkinson’s Research (MJFF)
- Mark J. Simon, President, Williver Group, LLC
- Barbara S. Slusher, PhD, MBA, Chief Scientific Officer, Brain Science Institute, Johns Hopkins School of Medicine
- Mary C. Tanner, Managing Director, Burrill & Company
- Christopher Yochim, Director, External Relations & Corporate Business Development, AstraZeneca
Sponsors and Partners
